Open tender · Estonia · Pharmaceutical products
Kasvajavastased ravimid, immunosupressandid, oftalmoloogias kasutatavad ravimid, hingamisteede obstruktiivsete haiguste raviks kasutatavad ravimid, migreenivastased ravimid
In EnglishAnticancer drugs, immunosuppressants, ophthalmological drugs, drugs for obstructive respiratory diseases, antimigraine drugs
sihtasutus Põhja-Eesti Regionaalhaigla
sihtasutus Põhja-Eesti Regionaalhaigla in Estonia is inviting bids for “Anticancer drugs, immunosuppressants, ophthalmological drugs, drugs for obstructive respiratory diseases, antimigraine drugs”. Bids close on 3 November 2026, 11:00 EET; the estimated value is €26.51 million. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Estimated value
- €26.51 million
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences